文献速递慢性肾脏病遗传性与小管间质肾病

肾小管FoxP2促进肾脏纤维化的机制研究

Tubular FoxP2 and Kidney Fibrosis.
PubMed 文献 · J Am Soc Nephrol · 2024-12-10

本研究探讨转录因子FoxP2在肾脏纤维化中的作用。人肾活检显示FOXP2在IgA肾病、膜性肾病和糖尿病肾病患者的肾小管核中表达显著增加。小鼠单侧输尿管梗阻和单侧缺血再灌注模型中,肾小管特异性敲除Foxp2减轻炎症和肾小管间质纤维化,并减少细胞周期阻滞。机制上,Foxp2通过激活上皮间质转化和G2/M细胞周期阻滞促进纤维化。

要点

  • FOXP2在多种CKD患者肾小管核中表达显著增加
  • 肾小管特异性敲除Foxp2减轻小鼠UUO和UIRI模型纤维化
  • Foxp2通过激活EMT和G2/M细胞周期阻滞促进纤维化

核心结论

  • Foxp2通过激活肾小管上皮间质转化和细胞周期阻滞促进肾脏纤维化,参与CKD进展。

研究设计与样本

  • 研究使用人肾活检评估FOXP2表达,并构建肾小管特异性Foxp2敲除小鼠应用于UUO和UIRI模型,同时使用培养的肾小管上皮细胞分析机制。

主要发现

  • FOXP2在IgA肾病、膜性肾病和糖尿病肾病患者肾小管核中表达显著增加。
  • 小鼠UUO和UIRI模型中,肾小管特异性敲除Foxp2减轻肾脏炎症和肾小管间质纤维化,并减少细胞周期阻滞。
  • 小鼠肾小管上皮细胞中,TGF-β通过Smad3信号上调Foxp2表达,敲低Foxp2抑制TGF-β诱导的EMT和细胞外基质蛋白积累。
  • Foxp2过表达抑制肾小管细胞增殖并诱导G2/M细胞周期阻滞。
  • ChIP-seq鉴定Foxp2靶基因富集于PI3K/AKT和TGF-β信号通路,Foxp2直接调控胶原-1、E-钙黏蛋白和p21的转录活性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: FOXP2/Foxp2 is overexpressed in human and in murine unilateral ureteral obstruction and unilateral ischemia-reperfusion models. Foxp2 overexpression mediates epithelial-to-mesenchymal transition and G2/M cell cycle arrest in kidney tubular cells to promote fibrosis. BACKGROUND: Kidney fibrosis is the final common pathway of progressive CKD that leads to kidney failure, for which there are limited therapeutic strategies. The transcription factor, Forkhead box P2 (Foxp2), has been implicated in organ development and tumorigenesis through its association with the epithelial-to-mesenchymal transition (EMT) process. In this study, we uncovered a novel role of Foxp2 in kidney fibrosis. METHODS: Human kidney biopsies were used to assess FOXP2 expression. Tubule-specific Foxp2 knockout mice were generated through LoxP-Cre transgenic manipulation and applied to murine models of progressive CKD, including unilateral ureteral obstruction (UUO) and unilateral ischemia-reperfusion injury (UIRI). Cultured kidney tubular epithelial cells were used to analyze the underlying cellular mechanisms. RESULTS: FOXP2 expression was markedly increased in the tubular nuclei of human kidney biopsies of CKD from patients with IgA nephropathy, membranous nephropathy, and diabetic nephropathy. In murine UUO and UIRI models that recapitulate progressive CKD, tubule-specific deletion of Foxp2 attenuated kidney inflammation and tubulointerstitial fibrosis, accompanied by reduction in cell cycle arrest. In mouse tubular epithelial cells, TGF-β upregulated Foxp2 expression through Smad3 signaling while knockdown of Foxp2 suppressed TGF-β-induced EMT and accumulation of extracellular matrix proteins. Mechanistically, overexpression of Foxp2 inhibited tubular cell proliferation with induction of G2/M cell cycle arrest. Using chromatin-immunoprecipitation sequencing, we identified Foxp2 target genes that are enriched in phosphatidylinositol 3-kinase/protein kinase B and TGF-β signaling pathways and further revealed that Foxp2 directly regulated the transcriptional activities of collagen-1, E-cadherin, and p21 that are involved in EMT and cell cycle arrest, thereby promoting the profibrotic process. CONCLUSIONS: Our findings demonstrate a novel role of Foxp2 in promoting kidney fibrosis in murine UUO and UIRI by activating EMT and cell cycle arrest in kidney tubules, contributing to the progression of CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zou Y, Yiu WH, Lok SWY, et al. Tubular FoxP2 and Kidney Fibrosis. J Am Soc Nephrol. 2024. PMID: 39656554. doi:10.1681/ASN.0000000576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。